Supported by Opella
Chair(s)
Mr Rob Moss, Bureau Member, International Pharmaceutical Federation, Netherlands
Introduction:
Join the Global Liver Health Forum and our symposium during the 83rd FIP World Congress of Pharmacy and Pharmaceutical Sciences.
What to expect? Leading expert talks on pharmacists’ pivotal role in supporting
patients with fatty liver disease:
Programme:
| 13:30 – 13:39 | Welcome and Introduction | |
| Mr Rob Moss, Bureau Member, International Pharmaceutical Federation, Netherlands | |
| 13:39 – 13:54 | Understanding MASLD: Risk Factors, Diagnosis, and Treatment Fundamentals |
| Prof. Norbert Stefan, University of the Hospital of Tubingen, Germany | |
| 13:54 – 14:09 | MASLD in Pharmacy Practice: Identifying Patient Profiles and Guiding Evidence-Based OTC Interventions |
| Assoc. Prof. Piotr Merks, Piktorex, Poland | |
| 14:09 – 14:24 | Panel Discussion on Integrating Perspectives |
| Prof. Norbert Stefan, University of the Hospital of Tubingen, Germany | |
| Assoc. Prof. Piotr Merks, Piktorex, Poland | |
| Assoc. Prof., Daniel Śliż, Polish Society of Lifestyle Medicine, Poland | |
| 14:24 – 14:30 | Key observations and closing remarks |
Stay ahead on liver health trends.
2. Learn evidence-based OTC strategies.
3. Get practical tips for daily pharmacy practice
4. FREE live webinar with real-time translation available
Scan the QR code to register and receive updates
